Analgesics in Lithuania

Analgesics in Lithuania

Analgesics in Lithuania is seeing robust rises in 2024, reversing the pattern seen in 2023, though value growth mostly results from price hikes. Post-pandemic, local consumers are once again self-medicating, supporting OTC sales. Paediatric analgesics are well-received as the major measure against fevers - a common condition seen in children during seasonal colds and flu. This is helping sales of Ibuprom and Nurofen, appealing to users due to their positive reputations. In addition, Diclofenac p...

Euromonitor International's Analgesics in Lithuania report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.